We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IOBT market cap is 100.8M. The company's latest EPS is USD -1.3066 and P/E is -1.16.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.87M | -20.39M | -17.92M | -21.85M | -23.48M |
| Net Income | -15.69M | -20.07M | -17.04M | -21.18M | -21.68M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -41.23M | -71.42M | -91.44M |
| Net Income | -74.99M | -71.46M | -86.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 162.16M | 151.81M | 136.84M | 117.56M | 172.55M |
| Total Liabilities | 8.67M | 12.95M | 12.63M | 13.04M | 14.96M |
| Total Equity | 153.49M | 138.85M | 124.22M | 104.52M | 157.59M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 222.29M | 151.81M | 150.72M |
| Total Liabilities | 10.36M | 12.95M | 17.56M |
| Total Equity | 211.92M | 138.85M | 133.16M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -47.2M | -59.73M | -14.69M | -32.95M | -48.94M |
| Investing | -341k | -690k | -148k | -187k | -211k |
| Financing | N/A | N/A | N/A | N/A | 71.87M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -40.65M | -59.73M | -71.74M |
| Investing | -153k | -690k | -323k |
| Financing | 252.95M | N/A | 71.86M |
| Market Cap | 100.8M |
| Price to Earnings Ratio | -1.16 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.7 |
| Price to Book Ratio | 0.75 |
| Dividend Yield | - |
| Shares Outstanding | 65.88M |
| Average Volume (1 week) | 61.31k |
| Average Volume (1 Month) | 92.71k |
| 52 Week Change | -19.47% |
| 52 Week High | 2.64 |
| 52 Week Low | 0.8163 |
| Spread (Intraday) | 0.25 (14.71%) |
| Company Name | IO Biotech Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.iobiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
